Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $44.65M | $45M | -0.78% |
Operating Income | $-342.28M | $-397.82M | +13.96% |
Net Income | $-316.91M | $-390.12M | +18.77% |
EPS (Basic) | $-2.99 | $-3.99 | +25.06% |
EPS (Diluted) | $-2.99 | $-3.99 | +25.06% |
R&D Expense | $300.21M | $349.43M | -14.09% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $925.27M | $1.17B | -21.14% |
Current Assets | $581.94M | $710.9M | -18.14% |
Total Liabilities | $176.85M | $210.74M | -16.08% |
Current Liabilities | $93.73M | $105.68M | -11.31% |
Stockholders' Equity | $748.42M | $962.62M | -22.25% |
Cash & Equivalents | $193.39M | $120.5M | +60.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-325.45M | $-263.69M | -23.42% |
Investing Cash Flow | $200.5M | $-26M | +871.20% |
Financing Cash Flow | $129.51M | $183.43M | -29.40% |
D&A | $7.39M | $7.72M | -4.30% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -766.5% | -884.0% | +117.46% |
Net Margin | -709.7% | — | — |
ROE | -42.3% | — | — |
ROA | -34.3% | — | — |
Current Ratio | $6.209 | — | — |
Debt to Equity | $0.236 | — | — |
Other companies in Biotechnology